Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

Exagen Diagnostics

Biotech & Life Sciences · Albuquerque, United States · Founded 2002 · IPO 2019 Colt

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation
$60M
Market cap · Apr/2026
Revenue
$67M
Latest reported FY

Investors

3 investors on Exagen Diagnostics's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Series A 2 investors entered at this stage
Tullis Health Investors
Cottonwood Technology Fund
Series B+ 1 investor entered at this stage
H.I.G. HealthBridge

Global footprint

Where Exagen Diagnostics has talent and traffic

AI talent share
0.9% of workforce is AI talent
(2 of 220 staff)
Core AI00%
Other AI20.91%
Non-AI workforce21899.09%
Web traffic by country
5.4K monthly visits
across markets
🇺🇸 United States100%
Top 1 markets shown

See Exagen Diagnostics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo